Testing effectiveness (Phase 2)Looking for participantsNCT06959771
What this trial is testing
Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study
Who this might be right for
CD40L-HyperIgM Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1